| Literature DB >> 29989059 |
Yuri Gorelik1, Said Darawshi1, Hiba Yaseen2, Zaid Abassi3, Samuel N Heyman4, Mogher Khamaisi1,2,3.
Abstract
INTRODUCTION: Acute kidney injury associated with near-drowning (ND-AKI) has rarely been reported and its incidence among survivors is unknown. A patient with AKI and urine biomarkers indicating tubular injury led us to assess the occurrence and clinical characteristics of ND-AKI and to evaluate possible causative mechanisms.Entities:
Keywords: acute kidney injury; gender; hypoxia; rhabdomyolysis
Year: 2018 PMID: 29989059 PMCID: PMC6035158 DOI: 10.1016/j.ekir.2018.02.007
Source DB: PubMed Journal: Kidney Int Rep ISSN: 2468-0249
Laboratory evaluation of the index case
| On arrival | 48 h | 72 h (discharge) | 9 mo (follow-up) | |
|---|---|---|---|---|
| pH | 7.12 | 7.32 | 7.41 | |
| pO2, mm Hg | 62 | 46 | 48 | |
| pCO2, mm Hg | 52 | 48 | 41 | |
| HCO3, mmol/l | 16.9 | 24 | 26 | |
| Lactate, mmol/l | 13.6 | 2.9 | 1.5 | |
| Sodium, mmol/l | 143 | 144 | 141 | 139 |
| Potassium, mmol/l | 3.3 | 3.9 | 4.7 | 4.3 |
| Chloride, mmol/l | 108 | 109 | 106 | 105 |
| Phosphate, mg/dl | 6.2 | 3.9 | 3.7 | 3.0 |
| Glucose, mg/dl | 121 | 118 | 84 | 78 |
| Creatinine, mg/dl | 1.09 | 2.22 | 1.67 | 0.78 |
| Blood urea nitrogen, mg/dl | 15 | 27 | 24 | 18 |
| Creatine kinase, IU/l | ND | 339 | 1445 | |
| Myoglobin, μg/l | ND | ND | 569 | |
| Uric acid, mg/dl | 6.9 | 5.0 | 3.8 | |
| AST, U/l | ND | 40 | 52 | |
| ALT, U/l | ND | 63 | 43 | |
| Osmolarity, mOsmol/kg | 363 | |||
| Sodium, mmol/l | 69 | |||
| Potassium, mmol/l | 11.8 | |||
| Protein, mg/dl | 80 | 7 | ||
| Myoglobin, μg/l | 7 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; ND, not determined.
Figure 1Comparisons of peak and Δ plasma creatinine between the specified groups. The boxplot demonstrates the range, median (solid line inside each box), and mean (triangle) of the highest plasma creatinine values in each group (blue boxes) and the difference between the highest and lowest creatinine values (Δ creatinine, red boxes). * P < 0.001 versus the 2 other groups (analysis of variance with Tukey post hoc test for multiple comparisons). Δ creatinine comparison between NO AKI and ND-AKI 1 falls short of statistical significance (P = 0.06). AKI, acute kidney injury; ND-AKI, acute kidney injury associated with near-drowning.
Figure 2Changes in plasma creatinine along the hospitalization course. Compared are the 3 study groups, NO AKI, AKI 1, and AKI 2–3, monitored during the first 120 hours following admission. Although plasma creatinine remained stable in the NO-AKI group, in general it was higher on admission in the AKI-1 group and declined subsequently, as opposed to the average values in the AKI-2–3 group that peaked on the second/third day and partially recovered later on. The symbol size reflects the number of observations, decreasing with time in all groups. Numbers adjacent to each time point represent SDs. Two-way analysis of variance reveals a P < 0.001 for both between-group and within-group variance. The test was restricted to the first 72 hours only, due to missing values of discharged patients at later time points. Creatinine values over time were significantly higher in the ND-AKI 2–3 group as compared with the 2 other categories (P < 0.001, Tukey post hoc test). A trend for higher cumulative creatinine values over time in the ND-AKI 1 group as compared with the NO-AKI group did not reach statistical significance (P = 0.12), but, as illustrated in Table 2, it was significantly higher on admission. AKI, acute kidney injury; ND-AKI, acute kidney injury associated with near-drowning.
Demographic, clinical, and laboratory features on admission in patients without and with AKI stages 1 and 2–3
| NO AKI, | ND-AKI 1, | ND-AKI 2–3, | ||
|---|---|---|---|---|
| Demographic | ||||
| Male gender (%) | 28/53 (52.8) | 15/25 (60) | 13/17 (76.5) | 0.22 |
| Age, mean ± SD (range) | 46.7 ± 23.0 (18–93) | 53.4±23.4 (20–88) | 49±18.7 (23–80) | 0.47 |
| Comorbidities | ||||
| Chronic kidney disease (%) | 4/52 (7.7) | 1/25 (4) | 1/17 (5.9) | 0.82 |
| Heart failure (%) | 1/53 (1.9) | 0/25 | 1/17 (5.9) | 0.42 |
| Diabetes (%) | 8/53 (15.1) | 6/25 (24) | 1/17 (5.9) | 0.28 |
| Hypertension (%) | 12/53 (22.6) | 10/25 (40) | 3/17 (17.6) | 0.18 |
| Coronary heart disease (%) | 5/53 (9.4) | 5/25 (20) | 0/17 (0) | 0.11 |
| Medications | ||||
| Diuretics (%) | 6/53 (11.3) | 4/25 (16.7) | 1/17 (5.9) | 0.57 |
| RAAS inhibitors (%) | 6/53 (11.3) | 6/25 (24) | 0/17 (0) | 0.05 |
| Clinical parameters at presentation | ||||
| On-site resuscitation (%) | 8/53 (15.4) | 8/25 (32) | 12/17 (70.6) | < 0.001 |
| Invasive ventilation (%) | 11/53 (20.8) | 13/25 (52) | 15/17 (88.2) | < 0.001 |
| Intensive care unit (%) | 14/53 (26.4) | 15/25 (60) | 13/17 (76.5) | < 0.001 |
| Temperature | 36.4 ± 0.9 | 36.2 ± 1.1 | 36 ± 1.7 | 0.47 |
| Heart rate, bpm | 93.3 ± 20.6 | 103.7 ± 28.5 | 108.1 ± 24.2 | 0.04 |
| Systolic blood pressure, mm Hg | 129.7 ± 26.3 | 126.8 ± 28.6 | 127.9 ± 25.9 | 0.91 |
| Diastolic blood pressure, mm Hg | 76.2 ± 15 | 75 ± 21.3 | 76.2 ± 16.2 | 0.96 |
| Atrial fibrillation on rescue | 2/35 (5.7) | 3/17 (17.6) | 4/11 (36.4) | 0.04 |
| pH | 7.2 ± 0.2 ( | 7.1 ± 0.2 ( | 7 ± 0.2 ( | < 0.001 |
| pCO2, mm Hg | 44.3 ± 16.3 ( | 52.2 ± 16.8 ( | 65.1 ± 21.7 ( | < 0.001 |
| HCO3, mmol/l | 19.2 ± 5.6 ( | 17 ± 6.3 ( | 15.1 ± 5.6 ( | 0.03 |
| Lactate, mmol/l | 7.7 ± 5.8 ( | 9.9 ± 5.2 ( | 14.8 ± 7 ( | < 0.001 |
| Glucose, mg/dl | 170.9 ± 63.4 ( | 222.3 ± 82.8 ( | 244.1 ± 98.2 ( | < 0.001 |
| Sodium, mmol/l | 143.7 ± 4.9 ( | 144.2 ± 5.7 ( | 149.9 ± 6.8 ( | < 0.001 |
| Potassium, mmol/l | 4.1 ± 0.6 ( | 4.1 ± 0.4 ( | 3.8 ± 0.6 ( | 0.15 |
| Chloride, mmol/l | 110.2 ± 15.1 ( | 110 ± 6.7 ( | 110.4 ± 6.5 ( | 0.99 |
| Hemoglobin, g/dl | 14.3 ± 1.7 ( | 14.1 ± 1.8 ( | 14.1 ± 1.6 ( | 0.86 |
| White blood cells, K/μl | 12.6 ± 4.5 ( | 15.3 ± 6.5 ( | 14.5 ± 4.6 ( | 0.08 |
| Platelets, K/μl | 259 ± 124.8 ( | 242.6 ± 81.2 ( | 240.2 ± 57 ( | 0.73 |
| Neutrophils, K/μl | 8.4 ± 4.4 ( | 9 ± 5.1 ( | 7.3 ± 4.8 ( | 0.55 |
| Lymphocytes, K/μl | 3.2 ± 2.1 ( | 5 ± 2.6 ( | 5 ± 2 ( | 0.002 |
| Creatinine, mg/dl | 1 ± 0.3 ( | 1.3 ± 0.3 ( | 1.3 ± 0.4 ( | < 0.001 |
| Blood urea nitrogen, mg/dl | 15.4 ± 5.6 ( | 17.8 ± 7.5 ( | 16.1 ± 6.6 ( | 0.3 |
| Albumin, g/dl | 3.7 ± 0.4 ( | 3.3 ± 0.5 ( | 3.2 ± 0.6 ( | 0.001 |
| Creatine kinase, IU/μl | 231 ± 163 ( | 1184 ± 1667 ( | 1988 ± 2824 ( | 0.01 |
| Calculated ingested sea water, ml | 418 ± 405 ( | 556 ± 516 ( | 1038 ± 626 ( | < 0.001 |
| Congestion on chest radiograph (%) | 29/50 (58) | 13/24 (54.2) | 10/17 (58.8) | 0.94 |
| Outcomes | ||||
| Length of stay, d | 3.3 ± 1.8 ( | 8.5 ± 7.4 ( | 25.1 ± 31.6 ( | < 0.001 |
| 90-day mortality (%) | 4 (7.5) | 3 (12) | 5 (29.4) | 0.06 |
AKI, acute kidney injury; bpm, beats per minute; ND-AKI, near-drowning acute kidney injury; RAAS, renin-angiotensin-aldosterone system.
Multiple regression analysis with the change in plasma creatinine as the dependent variable
| Independent variable | β | |
|---|---|---|
| Age, yr | 0.01 | 0.04 |
| pCO2 | 0.01 | 0.01 |
| Lactate | 0.05 | <0.001 |
| Sodium | 0.03 | 0.08 |
| Sex, male | 0.38 | 0.02 |
| Coronary heart disease, true | −0.61 | 0.03 |
β represents the change in the difference between highest and lowest creatinine value as a result of a change of 1 unit of the continuous independent variable or the presence of the categorical variable.
Literature review: acute renal failure following near-drowning
| Authors | Year | Study type | Age, yr | Gender | Saltwater | Proposed mechanism | Outcome | |
|---|---|---|---|---|---|---|---|---|
| Grausz H | 1971 | CR | 2 | 39, 26 | M | Y | Hypoxemia, hypoperfusion | Full recovery |
| Neale TJ | 1984 | CR | 2 | 32, 22 | M | Y | Rhabdomyolysis (traumatic), acute tubular necrosis | RRT before full recovery |
| Agar JW | 1994 | CR | 2 | 22, 45 | M | Y | Rhabdomyolysis | RRT before full recovery and recovery |
| Yoshitomi Y | 1998 | CR | 1 | 27 | M | N | Hypoxemia, acute tubular necrosis | RRT before full recovery |
| Spicer ST | 1999 | RCC | 15 | 33 ± 11 | 14/15 M | Y | Hypoxemia, hypoperfusion, rhabdomyolysis | Two died, 13 - fully recovered (2 underwent RRT before full recovery) |
| Bonnor R | 1999 | CR | 1 | 36 | M | Y | Hypothermia, rhabdomyolysis | RRT before full recovery |
| Lester JL | 2002 | CR | 1 | 28 | M | Y | Rhabdomyolysis | No follow-up |
| Hegde SN and Anupama YJ | 2003 | CR | 1 | 21 | M | N | Rhabdomyolysis | No follow-up |
| Hottelart C | 2004 | CR | 1 | 51 | M | Y | Hypothermia | RRT before full recovery |
| Seong EY | 2012 | CR | 1 | 21 | M | N | Acute tubular necrosis | Full recovery |
| Amir A and Lee YL | 2013 | CR | 1 | 20 | M | N | Hypoxemia, hypoperfusion | No follow-up |
CR, case report; F, female; M, male; RCC, retrospective case control; RRT, renal replacement therapy; Y, yes.